Form 4: Generation Bio Co. Executive Matthew Stanton Reports Stock Transactions
SEC Form 4 Filing
Matthew Stanton, Chief Scientific Officer of Generation Bio Co., reports the vesting and subsequent disposal of restricted stock units.
Summary
- On October 15, 2024, Matthew Stanton, the Chief Scientific Officer of Generation Bio Co., vested 1,674 restricted stock units, each representing the right to receive one share of the company's common stock.
- Stanton also disposed of 492 shares to cover tax obligations at a price of $2.42 per share.
- Following these transactions, Stanton directly owns 247,319 shares of common stock and 15,059 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and stock transactions, with no indication of unusual or concerning activity.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| January 20, 2023 | Reporting person was granted 26,775 restricted stock units. |
| January 15, 2024 | 25% of the restricted stock units vested. |
| October 15, 2024 | Vesting of 1,674 restricted stock units and disposal of 492 shares for tax obligations. |
| October 17, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.